84
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

, , , , , , & show all
Pages 719-731 | Published online: 02 Feb 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.